Open AccessCoronavirus Disease 19 (COVID-19) Pharmacologic Treatment
Author(s) -
Nikolina Bogdanić,
Ljiljana Lukić,
Josip Begovać
Publication year - 2021
Publication title -
infektološki glasnik
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.105
H-Index - 7
eISSN - 1848-7769
pISSN - 1331-2820
DOI - 10.37797/ig.40.4.4
Subject(s) - covid-19 , pandemic , outbreak , disease , medicine , coronavirus , virology , intensive care medicine , infectious disease (medical specialty) , pathology
Since the first cases of COVID-19 were reported from China the disease became pandemic within a few months. The viral genome was sequenced soon after the outbreak of COVID-19 which enabled development of diagnostic tests and therapeutic options. As the knowledge of SARS-CoV-2 virology increased, many potential drugs appeared. At this moment (January 12th 2021), 4426 studies of COVID-19 are registered, and more than 2680 studies are investigating therapeutic options. This is a short narrative review of currently available evidence on pharmacological treatment of COVID-19.